16:13 EDT Bionano Genomics offers to sell up to $35M in convertible senior notes due 2025
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BNGO:
- Bionano Genomics announces presentation of OGM utility
- Bionano Genomics implements streamlined operational plan
- Bionano Genomics sees Q3 revenue $9.1M-$9.3M, consensus $8.98M
- Bionano Genomics announces pricing of $80M registered offering
- Bionano Prices $80.0 Million Financing in Convertible Notes and Warrants, Announces Preliminary Q3 2023 Results, and Implements Streamlined Operational Plan